Sensus Healthcare, Inc. (SRTS)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Sensus Healthcare, Inc. (SRTS) is down 28.6% since the beginning of the year. At $3 per share, SRTS is trading 52.0% below its 52-week high of $6. Investors who bought $1,000 worth of SRTS shares 5 years ago would now be looking at an investment worth $814.

Sensus Healthcare, Inc. (SRTS) has returned -28.64% so far this year and -39.83% over the past 12 months.

Based on dividend-adjusted daily data since Jul 26, 2016, SRTS's average daily return is +0.08%, while the average monthly return is +1.17%. At this rate, an investment would double in approximately 5.0 years.

Historically, 46% of months were positive and 54% were negative. The best month was Nov 2021 with a return of +53.5%, while the worst month was Nov 2022 at -52.5%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 7 months.

On a daily basis, SRTS closed higher 47% of trading days. The best single day was May 10, 2024 with a return of +38.9%, while the worst single day was Nov 4, 2022 at -51.2%.

Sensus Healthcare, Inc. has an annualized alpha of 10.26%, beta of 0.78, and R2 of 0.04 versus S&P 500 Index. Calculated based on daily prices since July 27, 2016.

• This stock participated in 97.97% of S&P 500 Index downside but only 23.17% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.04 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

SRTS ranks 16 for risk / return — in the bottom 16% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Sensus Healthcare, Inc. (SRTS) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Sensus Healthcare, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Sensus Healthcare, Inc. was 87.51%, occurring on Nov 13, 2023. The portfolio has not yet recovered.

The current Sensus Healthcare, Inc. drawdown is 81.03%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Sensus Healthcare, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Sensus Healthcare, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.